SKI Market

Indian Indices

Sensex

83,576.24 -604.72
( -0.72%)

Global Indices

Nasdaq

49,277.91 260.82
(0.53%)

Dow Jones

6,942.18 0.25
(0.00%)

Hang Seng

51,918.01 800.75
(1.57%)

Nikkei 225

10,123.15 78.46
(0.78%)

Forex

USD-INR

89.93 -0.23
(-0.25%)

EUR-INR

105.10 -0.46
(-0.44%)

GBP-INR

121.29 -0.65
(-0.53%)

JPY-INR

0.57 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

43.97

868.48

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.2

Back

Cipla consolidated net profit rises 3.73% in the September 2025 quarter

Oct 30,2025

Net profit of Cipla rose 3.73% to Rs 1351.17 crore in the quarter ended September 2025 as against Rs 1302.53 crore during the previous quarter ended September 2024. Sales rose 6.98% to Rs 7447.42 crore in the quarter ended September 2025 as against Rs 6961.22 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	7447.42	6961.22	7
OPM %	25.44	27.09	-
PBDT	2150.52	2060.80	4
PBT	1853.53	1789.06	4
NP	1351.17	1302.53	4

83,576.24 -604.72 ( -0.72%)

49,277.91 260.82 (0.53%)

6,942.18 0.25 (0.00%)

51,918.01 800.75 (1.57%)

10,123.15 78.46 (0.78%)

89.93 -0.23 (-0.25%)

105.10 -0.46 (-0.44%)

121.29 -0.65 (-0.53%)

0.57 0.00 (-0.31%)